NF1 gene mutations lead to the inactivation or downregulation of neurofibromin, a negative regulator of the RAS system (Downward, 2003; Dasgupta et al., 2005), which results in excessive activation of the RAS system and tumor development. The gene discussed is NF1; the disease is neoplasm.